Vapotherm Competitors

Delisted . USA . 
Stock . Vapotherm
VAPODelisted Stock  USD 0.40  0.00  0.00%   
Vapotherm competes with Sight Sciences, STRATA Skin, Neuropace, Nexalin Technology, and Bone Biologics; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Vapotherm competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Vapotherm to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Vapotherm competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.400.400.40
Details
Intrinsic
Valuation
LowRealHigh
0.390.390.44
Details
Naive
Forecast
LowNextHigh
0.470.470.47
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.390.400.41
Details

Vapotherm Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Vapotherm and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Vapotherm and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Vapotherm does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TLIS
+ 0.87
SGHT
NXL
+ 0.77
NMRD
HSCS
+ 0.69
BBLG
NMRD
+ 0.56
NPCE
NXL
+ 0.55
NPCE
NMRD
+ 0.53
INVO
  
High negative correlations   
NXL
- 0.93
SGHT
NXL
- 0.92
TLIS
HSCS
- 0.73
NMRD
NMRD
- 0.68
TLIS
BBLG
- 0.64
NMRD
HSCS
- 0.58
NXL

Risk-Adjusted Indicators

There is a big difference between Vapotherm OTC Stock performing well and Vapotherm OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vapotherm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SGHT  3.18 (1.03) 0.00 (0.18) 0.00 
 0.00 
 6.96 
(7.84)
 18.22 
SSKN  3.09  0.17  0.03  0.36  3.78 
(3.36)
 8.83 
(7.20)
 20.44 
NPCE  3.51  0.32  0.14  0.25  3.00 
(4.30)
 9.73 
(6.19)
 35.38 
TLIS  4.85 (1.96) 0.00 (3.30) 0.00 
 0.00 
 5.32 
(10.69)
 68.77 
INVO  4.97  0.50  0.05 (0.47) 4.69 
(8.22)
 6.67 
(6.85)
 105.62 
NMRD  4.82  0.40  0.04 (0.65) 5.23 
(6.03)
 14.29 
(9.72)
 35.66 
NXL  8.33  2.59  0.33  2.00  6.68 
(11.18)
 25.71 
(12.22)
 71.17 
BBLG  9.17  0.80  0.09  0.62  8.80 
(14.72)
 18.13 
(17.14)
 163.17 
HSCS  5.11 (0.40) 0.00 (0.05) 0.00 
 0.00 
 11.44 
(8.97)
 58.33 
TIVC  4.75 (0.24) 0.00 (0.25) 0.00 
 0.00 
 12.12 
(6.90)
 79.31 
All Fundamental Data

Vapotherm Competitive Analysis

The better you understand Vapotherm competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Vapotherm's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Vapotherm's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
VAPO SGHT SSKN NPCE INVO NMRD NXL BBLG HSCS TIVC
 0.00 
 0.40 
Vapotherm
 6.65 
 4.01 
Sight
 1.61 
 3.05 
STRATA
 7.78 
 9.70 
Neuropace
 3.45 
 0.84 
INVO
 1.06 
 0.93 
Nemaura
 2.05 
 3.82 
Nexalin
 1.63 
 1.25 
Bone
 1.91 
 2.67 
Heart
 4.17 
 0.25 
Tivic
Market Volatility
(90 Days Market Risk)
Very steady
Relatively risky
Risky
Moderately volatile
Out of control
Very steady
Extremely Dangerous
Very risky
Dangerous
Out of control
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Weak
Modest
Insignificant
Very Weak
Solid
Insignificant
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Above Average
Very High
High
Dangerous
Dangerous
Below Average
High
Very High
Very High
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Under Valued
Under Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Buy
Strong Buy
Not Available
Not Available
Buy
Strong Buy
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Hold
Strong Sell
Cautious Hold
Not Rated
Not Rated
Cautious Hold
Strong Sell
Cautious Hold
Sell
Current Ratio
5.29
16.73
1.3
9.86
1.99
0.99
0.2
80.11
3.53
4.36
Net Asset
96.19 M
166.65 M
42.02 M
107.65 M
20.89 M
14.56 M
3.63 M
3.74 M
9.5 M
5.16 M
Profit Margin
-1.03
-0.63
-0.25
-0.37
-1.23
N/A
N/A
N/A
N/A
N/A
EBITDA
(72.13 M)
(49.41 M)
(3.38 M)
(22.83 M)
(6.63 M)
(8.17 M)
(5.69 M)
479.57 K
(6.16 M)
(8.06 M)
Operating Margin
-0.63
-0.56
-0.0576
-0.2
-1.04
N/A
-48.32
N/A
-379.07
-8.61
Current Valuation
102.76 M
118.82 M
22.14 M
306.2 M
15.19 M
22.58 M
46.19 M
(487.01 K)
(887.44 K)
(143.14 K)
Price To Book
7.11
2.13
1.36
29.47
5.97
122.56
9.91
0.81
0.41
0.72
Retained Earnings
(490 M)
(294.79 M)
(238.06 M)
(503.81 M)
(57.82 M)
(51.88 M)
(77.04 M)
(80.91 M)
(67.36 M)
(37.89 M)
Current Asset
2.57 M
N/A
9.39 M
N/A
N/A
9.55 M
N/A
1.07 M
N/A
N/A
Beta
-1.07
2.73
1.32
1.8
1.44
0.046
3.57
0.74
3.29
2.41
Number Of Employees
261
214
99
184
25
36
6
2
15
9
Shares Outstanding
6.14 M
50.4 M
4.17 M
29.85 M
3.91 M
28.9 M
12.86 M
2.46 M
913.82 K
8.27 M
Cash Flow From Operations
(80.16 M)
(47.18 M)
(519 K)
(19.7 M)
(4.76 M)
(8.45 M)
(3.84 M)
(9.56 M)
(6.07 M)
(8.51 M)
Total Debt
99.31 M
35.41 M
15.63 M
72.39 M
8.68 M
20.03 M
4.46 K
831.4 K
1.04 M
369 K
Return On Equity
-6.87
-0.45
-0.63
-2.15
-143.59
-7.24
-2.02
-1.19
-2.69
-1.84
Z Score
-8.36
N/A
N/A
N/A
N/A
-7.48
N/A
N/A
N/A
N/A
Return On Asset
-0.31
-0.19
-0.0679
-0.15
-0.27
-0.49
-1.19
-0.57
-0.82
-0.89
Number Of Shares Shorted
472.25 K
1.12 M
5.52 K
437.93 K
1.95 K
52.57 K
1.29 M
72.06 K
23.08 K
111.32 K
Book Value Per Share
-7.74
1.88
3.62
0.33
-1.59
-0.55
0.43
5.44
6.55
2.44
Current Liabilities
739 K
N/A
4.62 M
N/A
N/A
658.01 K
N/A
2.16 M
N/A
N/A
Total Asset
96.19 M
166.65 M
42.02 M
107.65 M
20.89 M
14.56 M
3.63 M
3.74 M
9.5 M
5.16 M
Debt To Equity
7.19
0.18
0.35
1.08
0.6
N/A
N/A
N/A
0.41
0.077
Short Ratio
12.93
7.27
0.44
6.35
0.04
0.3
0.56
0.18
0.49
0.12
Target Price
1.0
5.66
16.0
14.29
20.0
3.5
3.0
16.75
13.5
210.0
Shares Owned By Institutions
48.13
51.0
60.39
82.89
3.0
7.7
2.4
4.58
1.42
3.64
Market Capitalization
7.8 M
202.1 M
12.72 M
289.53 M
3.25 M
2.43 M
49.13 M
3.08 M
2.44 M
2.05 M
Price To Earnings To Growth
-0.04
N/A
-0.02
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
N/A
-0.49
N/A
N/A
-707.14
N/A
-15.45
N/A
N/A
Price To Sales
0.11
2.54
0.39
3.79
0.56
804.62
327.2
N/A
131.17
1.84
Net Income
(113.26 M)
(55.55 M)
(10.83 M)
(32.96 M)
(8.03 M)
(14.14 M)
(4.65 M)
(8.95 M)
(6.61 M)
(8.24 M)
Earnings Per Share
-14.33
-1.01
-2.6
-0.98
0.69
-0.39
-0.65
-1.46
-8.41
5.37
Shares Owned By Insiders
16.59
20.4
2.91
4.1
0.6
48.3
23.29
5.21
10.64
0.25
Revenue
66.8 M
81.06 M
33.36 M
65.42 M
3.02 M
77.04 K
110.75 K
N/A
18.6 K
1.18 M
Working Capital
40.34 M
150.62 M
3.37 M
76.49 M
(6.96 M)
(8.73 M)
3 M
2.91 M
5.6 M
3.25 M
Cash And Equivalents
49.88 M
220.1 M
10.04 M
92.41 M
1.96 M
14.75 M
291.33 K
5.45 M
4.27 M
9.06 M
Cash Per Share
1.87
4.6
0.29
3.72
0.16
0.61
0.06
0.53
0.52
0.94
Gross Profit
18.19 M
58.97 M
19.85 M
32.49 M
535.27 K
(1.48 M)
958.14 K
N/A
2.35 K
(129 K)
Day Typical Price
0.4
4.03
3.06
9.44
0.84
0.94
3.74
1.25
2.69
0.25
Accumulation Distribution
0.0714
0.0506
0.0258
0.0814
0.0805
0.1
0.1
0.0543
0.0681
0.0769
Market Facilitation Index
0.03
0.21
0.08
0.79
0.07
0.1
0.4
0.07
0.19
0.02
Daily Balance Of Power
N/A
1.190476
(0.62)
0.8861
(0.43)
(0.10)
(0.20)
0.2857
0.2632
0.5
Period Momentum Indicator
N/A
0.25
(0.05)
0.7
(0.03)
(0.01)
(0.08)
0.02
0.05
0.01
Rate Of Daily Change
1.0
1.07
0.98
1.08
0.97
0.99
0.98
1.02
1.02
1.04
Day Median Price
0.41
4.05
3.06
9.31
0.84
0.95
3.7
1.25
2.7
0.25
Price Action Indicator
(0.01)
0.09
(0.04)
0.74
(0.01)
(0.03)
0.08
0.005
N/A
0.005
Relative Strength Index
5.23
15.6
75.81
71.15
61.82
85.79
80.81
36.87
17.92
74.75
Coefficient Of Variation
(3,216)
(690.15)
1587.6
862.75
2968.94
2006.49
442.37
1947.72
(7,446)
(6,198)
Mean Deviation
4.98
3.18
3.09
3.51
4.97
4.82
8.33
9.17
5.11
4.75
Jensen Alpha
(0.27)
(1.03)
0.1694
0.3183
0.4998
0.3995
2.59
0.7962
(0.40)
(0.24)
Total Risk Alpha
(1.33)
(1.26)
(0.41)
(0.23)
(1.51)
(0.76)
0.8305
(2.08)
(1.37)
(1.62)
Sortino Ratio
N/A
N/A
0.0337
0.1427
0.0522
0.0364
0.3322
0.0902
N/A
N/A
Downside Variance
N/A
N/A
16.1
12.06
28.13
35.41
63.14
92.89
N/A
N/A
Standard Deviation
6.97
4.15
4.22
5.4
12.1
6.97
12.26
19.48
7.98
9.29
Kurtosis
0.9858
0.1335
0.7208
9.64
43.34
2.18
5.31
36.46
14.3
23.5
Potential Upside
15.38
6.96
8.83
9.73
6.67
14.29
25.71
18.13
11.44
12.12
Treynor Ratio
(0.69)
(0.18)
0.3571
0.2498
(0.47)
(0.65)
2.0
0.6173
(0.05)
(0.25)
Maximum Drawdown
34.31
18.22
20.44
35.38
105.62
35.66
71.17
163.17
58.33
79.31
Variance
48.64
17.22
17.83
29.21
146.3
48.54
150.23
379.32
63.67
86.37
Market Risk Adjusted Performance
(0.68)
(0.17)
0.3671
0.2598
(0.46)
(0.64)
2.01
0.6273
(0.04)
(0.24)
Risk Adjusted Performance
(0.01)
(0.10)
0.0565
0.0975
0.0352
0.0471
0.1827
0.049
(0)
(0)
Skewness
0.4714
(0.02)
0.4466
2.37
6.01
1.11
1.65
5.21
2.78
3.83
Semi Deviation
N/A
N/A
3.78
3.0
4.69
5.23
6.68
8.8
N/A
N/A
Information Ratio
(0.05)
(0.18)
0.032
0.0917
0.0229
0.0311
0.2154
0.0446
(0.03)
(0.03)
Value At Risk
(11.63)
(7.84)
(7.20)
(6.19)
(6.85)
(9.72)
(12.22)
(17.14)
(8.97)
(6.90)
Expected Short fall
N/A
N/A
(3.36)
(4.30)
(8.22)
(6.03)
(11.18)
(14.72)
N/A
N/A
Downside Deviation
N/A
N/A
4.01
3.47
5.3
5.95
7.95
9.64
N/A
N/A
Semi Variance
N/A
N/A
14.32
9.03
21.96
27.4
44.66
77.43
N/A
N/A

Vapotherm Competition Performance Charts

Five steps to successful analysis of Vapotherm Competition

Vapotherm's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Vapotherm in relation to its competition. Vapotherm's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Vapotherm in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Vapotherm's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Vapotherm, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Vapotherm position

In addition to having Vapotherm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Blend Funds Thematic Idea Now

Large Blend Funds
Large Blend Funds Theme
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Vapotherm OTC Stock

If you are still planning to invest in Vapotherm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vapotherm's history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY